Free Trial

Scienture Q1 2023 Earnings Report

$7.58 -0.55 (-6.77%)
(As of 12/20/2024 05:16 PM ET)

Scienture EPS Results

Actual EPS
-$0.45
Consensus EPS
-$0.30
Beat/Miss
Missed by -$0.15
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$2.25 million
Expected Revenue
$2.47 million
Beat/Miss
Missed by -$220.00 thousand
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

View Scienture Profile

More Earnings Resources from MarketBeat

Upcoming Earnings